HI
BLPH

Harbour Investments’s Bellerophon Therapeutics, Inc. BLPH Stock Holding History

Harbour Investments’s Portfolio BLPH Stock Details BLPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-241
Closed -$1K – 4035
2021
Q3 		$1K Buy
241
+99
+70% +$413 ﹤0.01% 3687
2021
Q2 		$1K Buy
142
+4
+3% +$18 ﹤0.01% 3730
2021
Q1 		$1K Buy
+138
New +$961 ﹤0.01% 3567

Other funds holding BLPH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Harbour Investments's BLPH Position: Q4 2021 in Review

Harbour Investments sold out of Bellerophon Therapeutics, Inc. (BLPH) in Q4 2021, closing a stake of 241 shares — an estimated $1K sold.

Harbour Investments first reported a position in BLPH in Q1 2021 and held it in 3 quarters. The position peaked at $1K in Q3 2021. 22 funds tracked by Wall St. Rank hold BLPH as of Q4 2021.

  • Harbour Investments reported no remaining Bellerophon Therapeutics, Inc. position as of Q4 2021 after selling out during the quarter.
  • Harbour Investments sold 241 Bellerophon Therapeutics, Inc. shares in Q4 2021, an estimated $1K.
  • Harbour Investments first reported a position in Bellerophon Therapeutics, Inc. in Q1 2021 and held it in 3 quarters.
  • Harbour Investments's Bellerophon Therapeutics, Inc. position peaked at $1K in Q3 2021.
  • 22 funds tracked by Wall St. Rank held Bellerophon Therapeutics, Inc. as of Q4 2021.

Based on Harbour Investments's 13F filing for Q4 2021, filed 16 Feb 2022.